Study to Characterize the Pharmacokinetics of 3 Marketed Products Containing 200 mg Guaifenesin in Healthy Volunteers.
Phase 1
Completed
- Conditions
- Healthy Subjects
- Interventions
- Drug: Robitussin Extra Strength Chest CongestionDrug: Vicks Cough Syrup for Chesty CoughsDrug: Organ-I- NR tablet
- First Posted Date
- 2018-08-23
- Last Posted Date
- 2019-03-27
- Lead Sponsor
- Reckitt Benckiser Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT03643575
Study to Evaluate the Pharmacokinetics of Mucinex 600 mg Extended-release Bi-layer Tablet in Healthy Volunteers
- First Posted Date
- 2018-08-23
- Last Posted Date
- 2019-02-28
- Lead Sponsor
- Reckitt Benckiser Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT03644108
Bioequivalence Study Comparing Mucinex Extended-release 600 mg Tablets to Immediate-release Guaifenesin 600 mg in Healthy Volunteers
Phase 1
Completed
- Conditions
- Healthy Subjects
- Interventions
- Drug: Vicks Cough Syrup for Chesty Coughs
- First Posted Date
- 2018-08-23
- Last Posted Date
- 2019-06-19
- Lead Sponsor
- Reckitt Benckiser Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT03644095
Mucinex® ER 600 mg Bi-layer Tablet Versus Guaifenesin Immediate Release (IR) 200 mg q4h
- First Posted Date
- 2018-08-22
- Last Posted Date
- 2019-06-17
- Lead Sponsor
- Reckitt Benckiser Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT03642262
Safety and Efficacy Study of Guaifenesin and Pseudoephedrine for Symptomatic Therapy to Treat Acute RTI
Phase 4
Completed
- Conditions
- Acute Upper Respiratory Track Infection
- Interventions
- Device: Placebo
- First Posted Date
- 2010-09-15
- Last Posted Date
- 2020-12-30
- Lead Sponsor
- Reckitt Benckiser Inc.
- Target Recruit Count
- 1179
- Registration Number
- NCT01202279
- Locations
- 🇺🇸
Coastal Connecticut Research, LLC, 342 Montauk Avenue, New London, Connecticut, United States
🇺🇸Clinical Associates Research, 750 Main Street, Suite 310, Reisterstown, Maryland, United States
🇺🇸Clinical Research Advantage, Inc., Mesa, Arizona, United States
Mucinex Exploratory Cold Study
- First Posted Date
- 2010-01-11
- Last Posted Date
- 2020-12-30
- Lead Sponsor
- Reckitt Benckiser Inc.
- Target Recruit Count
- 378
- Registration Number
- NCT01046136
- Locations
- 🇺🇸
Pioneer Clinical Research, Bellevue, Nebraska, United States
© Copyright 2025. All Rights Reserved by MedPath